Inhibition of Borna disease virus replication by ribavirin in persistently infected cells

Archives of Virology

Volumn 143, Issue 10, 1998, Pages 2039-2044

  Mizutani, T ^a   Inagaki, H ^a   Araki, K ^a   Kariwa, H ^a   Arikawa, J ^b   Takashima, I ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRAL ACTIVITY; BORNA DISEASE VIRUS; RIBAVIRIN; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; BORNA DISEASE VIRUS; CELL LINE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RIBAVIRIN; VIRUS REPLICATION;

BORNA DISEASE VIRUS;

EID: 0031732058     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050440     Document Type: Article

References (27)

1. Bode L, Zimmermann W, Ferszt R, Steinbach F, Ludwig H (1995) Borna disease virus genome transcribed and expressed in psychiatric patients. Nature Med 1: 232-236
2. Bode L, Dietrich DE, Stoyloff R, Emrich HM, Ludwig H (1997) Amantadine and human Borna disease virus in vitro and in vivo in an infected patient with bipolar depression. Lancet 349: 178-179
3. Briese T, Schneemann A, Lewis AJ, Park YS, Kim S, Ludwig H, Lipkin WI (1994) Genomic organization of Borna disease virus. Proc Natl Acad Sci USA 91:4 362-4 366
4. Carbone KM, Rubin SA, Sierra-Honigmann AM, Lederman HM (1993) Characterization of a glial cell line persistently infected with Borna disease virus (BDV): influence of neurotrophic factors on BDV protein and RNA expression. J Virol 67: 1 453-1 460
5. Cubitt B, Oldstone C, de la Torre JC (1994) Sequence and genome organization of Borna disease virus. J Virol 68: 1 382-1 396
6. Cubitt B, de la Torre JC (1997) Amantadine does not have antiviral activity against Borna disease virus. Arch Virol 142: 2035-2042
7. Fernandez H, Banks G, Smith R (1986) Ribavirin: a clinical overview. Eur J Epidemiol 2: 1-14
8. Fernandez LR, O'Connell K, Koumans E, Patterson JL (1989) Molecular analysis of the inhibitory effect of phosphorylated ribavirin on the vesicular stomatitis virus in vitro polymerase reaction. Antimicrob Agents Chemother 33: 1 668-1 673
9. Fernandez LR, Patterson JL (1990) Ribavirin is an inhibitor of human immunodeficiency virus reverse transcriptase. Mol Pharmacol 38: 766-770
10. Gonzalez-Dunia D, Cubitt B, de la Torre JC (1988) Mechanism of Borna disease virus entry into cells. J Virol 72: 783-788
11. Goswami BB, Borek E, Sharma OK (1979) The broad spectrum antiviral agent ribavirin inhibits capping of mRNA. Biochem Biophys Res Commun 89: 830-836
12. Hallensleben W, Zocher M, Staeheli P (1997) Borna disease virus is not sensitive to amantadine. Arch Virol 142: 2043-2048
13. Herzog S, Rott R (1980) Replication of Borna disease virus in cell cultures. Med Microbiol Immunol 168: 153-158
14. Kishi M, Nakaya T, Nakamura Y, Kakinuma M, Zhong Q, Ikeda K, Senjo M, Kakinuma M, Kato S, Ikuta K (1995) Demonstration of human Borna disease virus RNA in human peripheral blood mononuclear cells. FEBS Lett 364: 293-297
15. Knight V, Gilbert B (1988) Antiviral therapy with small particle aerosols. Eur J Clin Microbiol Infect Dis 7: 721-731
16. Patterson JL, Fernandez LR (1990) Molecular mechanisms of action of ribavirin. Rev Infect Dis 12: 1 139-1 146
17. Peavy DL, Powers CN, Knight V (1981) Inhibition of murine plaque-forming cell responses in vivo by ribavirin. J Immunol 126: 861-864
18. Prusiner P, Sundaralingam M (1973) A new class of synthetic nucleoside analogues with broad spectrum antiviral properties. Nature (London) New Biol 244: 116-118
19. Rankin JT, Eppes SB, Antczak JB, Joklik WK (1989) Studies on the mechanism of the antiviral activity of ribavirin against reovirus. Virology 168: 147-58
20. Rott R, Becht H (1995) Natural and experimental Borna disease in animals. Curr Top Microbiol Immunol 190: 17-30
21. Sauder C, Müller A, Cubitt B, Mayer J, Steinmetz J, Trabert W, Ziegler B, Wanke K, Mueller-Lantzsch N, de la Torre JC, Grässer FA (1996) Detection of Borna disease virus (BDV) antibodies and BDV RNA in psychiatric patients: evidence for high sequence conservation of human blood-derived BDV RNA. J Virol 70: 7713-7724
22. Schneider PA, Briese T, Zimmermann W, Ludwig H, Lipkin WI (1994) Sequence conservation in field and experimental isolates of Borna disease virus. J Virol 68: 63-68
23. Schneider PA, Hatalski CG, Lewis AJ, Lipkin WI (1997) Biochemical and functional analysis of the Borna disease virus G protein. J Virol 71: 331-336
24. Sidwell RW, Robins RK, Hillyard IV (1979) Ribavirin: an antiviral agent. Pharmacol Ther 6: 123-146
25. Sidwell RW, Bailey KW, Wong MH, Huffman JH (1995) In vitro and in vivo sensitivity of a non-mouse-adapted influenza A (Beijing) virus infection to amantadine and ribavirin. Chemotherapy 41: 455-461
26. Rott R, Bechet H (1995) Natural and experimental Borna disease in animals. In: Koprowski H, Lipkin I (eds) Borna disease. Springer, Berlin Heidelberg New York Tokyo, pp 17-30
27. Wehner T, Ruppert A, Herden C, Frese K, Becht H, Richt JA (1997) Detection of a novel Borna disease virus-encoded 10 kDa protein in infected cells and tissues. J Gen Virol 78: 2 459-2 466